Loading grant details…
Enabling the next generation in search of blood cancer cures
| Funder | European Commission |
|---|---|
| Recipient Organization | Fundacio Institut de Recerca Contra la Leucemia Josep Carreras |
| Country | Spain |
| Start Date | Sep 01, 2024 |
| End Date | Aug 31, 2029 |
| Duration | 1,825 days |
| Number of Grantees | 47 |
| Roles | Associated Partner; Coordinator |
| Data Source | European Commission |
| Grant ID | 101126688 |
Grant Description
The CarrerasPathfinder program is new a world-wide unique doctoral program that covers the entire spectrum of research and innovation in blood cancers from understanding disease biology to the implementation of novel processes in the clinical practice. The program will fund 14 excellent Doctoral Candidates (DCs) for a period of 48 months.
DCs will perform collaborative PhD projects involving associated partners from different sectors, countries, and disciplines through secondments.
DCs will improve their research capacity and transferable skills through high-quality supervision arrangements and a tailored training program.The program has been designed and will be hosted by the Josep Carreras Leukaemia Research Institute (IJC) which is the first European non-profit institute exclusively devoted to blood cancers.
By answering the European needs for human resources, it is fully aligned with the 13 recommendations of the EU Cancer Board’s Draft Mission and the Europe’s Beating Cancer Plan (2021).
The CarrerasPathfinder program has a strong triple-I dimension of internationality, inter-sectorality and interdisciplinarity in training, networking, co-supervision and research.
Its specific objectives are:•To develop an excellent doctoral program in blood cancer research conceived as a pilot for a permanent international doctoral program•To equip DCs with a unique skill set boosting effectiveness and innovation capacity. •To promote DCs’ career development and increase their employability in different sectors.•To establish the IJC as a European reference for research and training in blood cancers.•To provide Europe with a new generation of researchers able to address unmet needs and societal challenges of blood cancers.•To contribute to structuring the European research area by collaborating and synergizing with other European key opinion leaders.
All Grantees
University of Sharjah; Applied Nanoparticles Sl; Consorcio Para la Construccion Equipamiento Y Explotacion Del Laboratorio de Luz Sincrotron; Fundació Internacional Josep Carreras; Asociacion Eit Health Spain; Fundacion Para El Conocimiento Madrimasd; Fundacio Institucio Dels Centres de Recerca de Catalunya; Ustav Molekularni Genetiky Av Cr V.V.I.; Anaxomics Biotech Sl; University of Newcastle Upon Tyne; Deutsches Krebsforschungszentrum Heidelberg; Universita Degli Studi Di Torino; Specialized Hospital for Active Treatment of Hematological Diseases; Ecole Polytechnique Federale de Lausanne; Universite Libre de Bruxelles; European Hematology Association; Applied Research Using Omic Sciences Sl; Agencia Estatal Consejo Superior de Investigaciones Cientificas; Trustees of Columbia University in the City of New York; New York University; Fundacio Institut de Recerca Biomedica (Irb Barcelona); Gavin Lucas; Universitat de Barcelona; Charite - Universitaetsmedizin Berlin; Fondazione Per L'Istituto Oncologico Di Ricerca (Ior); Mesoestetic Pharma Group S.L.; Humanitas Mirasole Spa; Asociación Española Contra El Cáncer; Universitetet I Oslo; Scienseed Sl; Semmelweis Egyetem; Onkoloski Institut Ljubljana; Quimatryx Sl; Fundacion Cientifica de la Asociación Espanola Contra El Cancer; Institutul National de Cercetare - Dezvoltare in Domeniul Patologiei Si Stiintelor Biomedicale Victor Babes Ra; Instituto de Medicina Molecular Joao Lobo Antunes; International Society for Experimental Hematology; Biocat la Fundacio Bioregio de Catalunya; Universitat Autonoma de Barcelona; Onechain Immunotherapeutics S.L.; Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften Ev; Biomedicinske Centrum Slovenskej Akademie Vied, Verejna Vyskumna Institucia; University of Cyprus; Novogene Uk Company Limited; Mll Munchner Leukamielabor Gmbh; Fundacio Institut de Recerca Contra la Leucemia Josep Carreras; Barcelona Supercomputing Center Centro Nacional de Supercomputacion
Interested in applying for this grant?
Complete our application form to express your interest and we'll guide you through the process.
Apply for This GrantQuick Summary
Related Grants
